ArticleBioengineering & translational medicine2022

Two diverse carriers are better than one: A case study in α-particle therapy for prostate specific membrane antigen-expressing prostate cancers.

Dominick Salerno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.